BASILEA PHARMACEUTICA

Live / Applied — First extension granted (statement of use) (as of 16 Jan 2026)

What this means for you

Not registered yet, but its 20 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98610677
Mark type
Stylized text
Filed
20 Jun 2024
Published for opposition
20 May 2025
Attorney of record
Evan A. Raynes

Goods and services

  • Class 001 — Chemicals: chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents, other than for medical or veterinary purposes
  • Class 005 — Pharmaceuticals: diagnostic reagents for medical or veterinary purposes; pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents
  • Class 042 — Scientific and technological services: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Owner

Prosecution history

  • 16 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 16 Jan 2026 — SOU EXTENSION 1 GRANTED
  • 15 Jan 2026 — SOU EXTENSION 1 FILED
  • 15 Jan 2026 — SOU TEAS EXTENSION RECEIVED
  • 15 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 20 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 20 May 2025 — PUBLISHED FOR OPPOSITION
  • 14 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 21 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 31 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
  • 31 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 31 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
  • 31 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 25 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 25 Jan 2025 — NON-FINAL ACTION E-MAILED

View this trademark record on Marksy